I am actually in total agreement with STEW on this one. I came in late, but the study cited showed NO evidence of enhancement of muscular contractile potential. In fact, the receptors that it did modulate, the benzo/GABA receptors, are neuroINHIBITORY. Who takes Xanax or Valium and then trains hard? Nobody...these drugs turn one into a zombie, due to reduction in neural transmission. If you read this study again, it states that "androgenic/anabolic steroids modulate in vitro ligand binding to the benzodiazepine binding site(s) associated with the gamma-aminobutyric acidA (GABAA) receptor complex (Masonis and McCarthy, 1995). " This means that other steroids have this ability also, thus it is not unique to stanazolol.
As for all this "Class I and Class II" classification of steroids, remember, this is not a supported classification scheme. Bill Roberts came up with this, and while as bright as he is, he is still the only one who uses this system. Pat Arnold has come out rejecting this system of classification.
The research only supports AR agonism as the major pathway of anabolic processes. And if you want to get more into it, aromatization plays a key role in GH/IGF elevations.
"I haven't studied estrogen to any large extent so I don't know the direct method of involvemen with it and IGF-1."
Estrogen increases insulin levels, as well as GH pulsatility, which both directly elevate IGF levels.